Wael Khreisat | Pediatrics | Best Researcher Award

Published on by Academic Achievements

Dr. Wael Khreisat | Pediatrics | Best Researcher Award 

Dr. Wael Khreisat | Pediatrics | Neurologist at Royal Rehabilitation Center at Jordan

Pediatrics is the foundation of Dr. Wael Khreisat’s distinguished clinical and academic journey, defining his excellence in child neurological health, neurodevelopmental rehabilitation, and evidence-based diagnostic and therapeutic pediatric practices. As a highly dedicated Pediatric Neurologist serving at the esteemed Royal Rehabilitation Center in Jordan, Dr. Wael Khreisat has devoted his career to improving the clinical outcomes and quality of life of children suffering from complex neurological conditions, neurodevelopmental disorders, cerebral palsy, epilepsy, neuromuscular disorders, traumatic brain injuries, and behavioral neurodevelopmental disabilities. His professional identity blends deep medical expertise, compassionate patient care, and strong advocacy for early childhood neurological support, ensuring clinical interventions that improve long-term neurocognitive development. Dr. Wael Khreisat’s academic foundation is built upon rigorous medical education and specialized neurological training, culminating in pediatric subspecialization that has positioned him as one of Jordan’s leading experts in neuro-rehabilitation. His professional experience extends across outpatient and inpatient pediatric services, interdisciplinary rehabilitation programs, neuro-assessment clinics, and neurological diagnostics, bridging multidisciplinary teamwork and patient-centered therapeutic approaches. His research interest lies in pediatric neurology, clinical neurodevelopment, neurorehabilitation technologies, cerebral palsy management, neuroplasticity, and long-term outcomes of pediatric neurological interventions. He actively pursues research that investigates diagnostic innovations, neurological rehabilitation strategies, pediatric neurophysiology, and the integration of early rehabilitative therapy models, contributing to clinical protocols that are increasingly adopted across rehabilitation centers in the region. Throughout his medical career, Dr. Wael Khreisat has acquired core research, diagnostic, and clinical skills including EEG interpretation, neurological disorder assessment, rehabilitation program structuring, neurodevelopmental screening, clinical decision-making, and multidisciplinary therapeutic coordination. His dedication to academic pursuit has earned him recognition in scholarly communities and he has been honored with the Best Researcher Award, acknowledging the regional and clinical impact of his academic contributions in Pediatrics. Dr. Wael Khreisat has also contributed significantly to professional development within pediatric neurology through conference participation, case study reporting, and knowledge dissemination in interdisciplinary medical environments. His contributions emphasize holistic pediatric care, accurate clinical diagnosis, early interventions, functional rehabilitation, and psychosocial support tailored to child and family needs. As a pediatric neurologist integrated into a national rehabilitation center, his work reflects a compassionate commitment to children’s neurological health while advancing medical excellence across Jordan. Conclusively, Dr. Wael Khreisat represents a strong model of medical professionalism, scientific advancement, and community-centered healthcare practice in Pediatrics, consistently striving to deliver evidence-led treatments that elevate neurodevelopmental outcomes and empower families, rehabilitation teams, and the broader medical community.

Profile: ORCID

Featured Publications

  1. Khreisat, W. (2024, December 11). An evaluation of whether routine QTc interval screening is necessary prior to starting ADHD medications: Experience from a large retrospective study. Pediatric Reports.
  2. Khreisat, W. (2024, January 26). Atomoxetine treatment of attention deficit/hyperactivity disorder symptoms in 3–6-year-old children with autism spectrum disorder: A retrospective cohort study. Children (Basel, Switzerland).
  3. Khreisat, W. (2022, July 19). The role of clinical pharmacist in pediatrics’ adherence to antiepileptic drugs. The Journal of Pharmacy Technology, 38(4), 256–263.
  4. Khreisat, W. (2020, October). Genetic association of epilepsy and anti-epileptic drugs treatment in Jordanian patients. Pharmacogenomics and Personalized Medicine.
  5. Khreisat, W. (2019, September). Genetic polymorphisms of CYP3A5, CHRM2, and ZNF498 and their association with epilepsy susceptibility: A pharmacogenetic and case–control study. Pharmacogenomics and Personalized Medicine.
  6. Khreisat, W. (2019, June). Effects of MTHFR and ABCC2 gene polymorphisms on antiepileptic drug responsiveness in Jordanian epileptic patients. Pharmacogenomics and Personalized Medicine.
  7. Khreisat, W. (2018). The impact of potassium channel gene polymorphisms on antiepileptic drug responsiveness in Arab patients with epilepsy. Journal of Personalized Medicine, 8(4), 37.
  8. Khreisat, W. (2011). Clinical applications of electroencephalogram in children. Basic and Clinical Neuroscience.

Xinhui LUO | Paediatrics | Best Researcher Award

Published on by Academic Achievements

Dr. Xinhui LUO | Paediatrics | Best Researcher Award

Dr. Xinhui LUO | Paediatrics – Chief physician at Children’s Hospital of Xinjiang Uygur Autonomous Region, China

Dr. Luo Xinhui is a highly accomplished pediatric specialist and healthcare leader, currently serving as the Chief Physician and Vice President at the Children’s Hospital of Xinjiang Uygur Autonomous Region. With over two decades of clinical, academic, and administrative experience, she is known for her impactful research, outstanding medical service, and contributions to pediatric care reform in China. Her work bridges clinical practice with research innovation, especially in child respiratory diseases, genetic influences on treatment outcomes, and pediatric infectious diseases. A respected mentor and role model, Dr. Luo is committed to elevating pediatric healthcare both regionally and nationally.

Profile Verified

ORCID 

Education

Dr. Luo completed her Master’s Degree in Pediatrics in June 2009. Her academic foundation is rooted in a strong clinical curriculum, advanced medical research training, and hands-on experience in pediatric diagnosis and treatment. Throughout her education, she demonstrated exceptional academic excellence, developing a lifelong passion for translational research and child health advocacy.

Professional Experience

Dr. Luo began her medical career in 2004 as Deputy Director of Pediatrics at the People’s Hospital of Xinjiang Uygur Autonomous Region. In 2015, she was promoted to Director of Pediatrics and also led the Pediatric Research Institute. Since 2017, she has been the Vice President of the Children’s Hospital of Xinjiang, where she oversees clinical operations, directs research initiatives, and trains young pediatricians. Her leadership has significantly improved pediatric healthcare delivery and research capabilities in the region.

Research Interests

Dr. Luo’s research interests lie at the intersection of clinical pediatrics and public health. She focuses on respiratory tract infections, nutritional deficiencies, pediatric tuberculosis, gastrointestinal bleeding in infants, and food allergies in early childhood. She has led several government-funded projects investigating the relationships between vitamin levels, immune function, genetic markers, and pediatric disease outcomes. Her commitment to evidence-based practice and translational research has led to meaningful changes in clinical treatment protocols for children.

Awards and Recognitions

Dr. Luo has received numerous prestigious awards in recognition of her contributions to medical research and healthcare leadership. She was honored with the Achievement Transformation Award in Medical Research (First Place) by the Chinese Research Hospital Association. The Outstanding Contributor to Healthcare Service Improvement award was conferred by the National Health Commission. She also received top honors for her leadership in the Standardized Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia and was recognized as an Outstanding Director of Teaching and Research Office by the Chinese Medical Doctor Association. These accolades underscore her impact on clinical excellence, teaching innovation, and research advancement.

Selected Publications

  • 🫁 “Controversies in Pediatric Asthma: A Bibliometric Evaluation”, Pediatric Pulmonology, 2025 – cited by 8 articles.
  • 🧬 “MTHFR Gene Polymorphism and Methotrexate Side Effects in Children”, Chinese Journal of Pediatrics, 2023 – cited by 15 articles.
  • 🦠 “IL-9 Gene Expression in the Diagnosis of Pediatric Tuberculosis”, Journal of Clinical Pediatrics, 2022 – cited by 12 articles.
  • 🥦 “Correlation Between Vitamin A/E Levels and Respiratory Infections in Children”, Frontiers in Pediatrics, 2021 – cited by 10 articles.
  • 🍼 “Vitamin K Deficiency and Risk Factors of GI Bleeding in Infants”, Journal of Pediatric Gastroenterology, 2020 – cited by 9 articles.
  • 🌿 “Gut Microbiota and Food Allergies in Infants”, Microbial Health in Pediatrics, 2019 – cited by 6 articles.
  • 🧪 “Clinical Study on Pediatric Leukemia Standardized Treatment Outcomes”, Medical Science Monitor, 2018 – cited by 11 articles.

Conclusion

Dr. Luo Xinhui’s career reflects a profound dedication to advancing pediatric medicine through research, education, and clinical leadership. Her sustained excellence in conducting impactful, government-funded research and her role in shaping child health policies make her an outstanding candidate for the Best Researcher Award. Her contributions continue to elevate healthcare standards, inspire future pediatricians, and address critical health challenges facing children today. With her remarkable achievements and unwavering commitment to improving lives, Dr. Luo is undoubtedly deserving of this prestigious recognition.